Metapristone

Metapristone is a chemical compound that is primarily known for its potential applications in medicine. It is a derivative of the well-known drug mifepristone, which is used for medical abortion and as a glucocorticoid receptor antagonist.
Chemical Structure and Properties[edit]
Metapristone, also known by its chemical name RU-42633, is structurally related to mifepristone. It shares a similar core structure but has modifications that may alter its pharmacological properties. The exact chemical structure of metapristone includes a steroidal backbone with specific functional groups that contribute to its activity.
Pharmacology[edit]
Metapristone acts as an antagonist to the progesterone receptor and the glucocorticoid receptor. This dual antagonistic activity makes it a compound of interest for various therapeutic applications. Its ability to block progesterone receptors is similar to that of mifepristone, which is used to terminate early pregnancies by inhibiting the action of progesterone, a hormone necessary for pregnancy maintenance.
Potential Medical Applications[edit]
Research into metapristone has suggested several potential medical applications:
- **Cancer Treatment**: Metapristone has been studied for its potential use in the treatment of certain types of cancer, particularly those that are hormone-dependent. Its ability to block hormone receptors may help in slowing the growth of hormone-sensitive tumors.
- **Anti-inflammatory Effects**: By antagonizing the glucocorticoid receptor, metapristone may have anti-inflammatory properties. This could make it useful in treating conditions characterized by excessive inflammation.
- **Endometriosis**: Similar to mifepristone, metapristone may be useful in the treatment of endometriosis, a condition where tissue similar to the lining inside the uterus grows outside the uterus, causing pain and potentially leading to infertility.
Research and Development[edit]
While metapristone shows promise in various therapeutic areas, it is still under investigation. Clinical trials and further research are necessary to fully understand its efficacy and safety profile. The development of metapristone as a therapeutic agent involves rigorous testing to ensure it meets the standards required for medical use.
See Also[edit]
References[edit]
External Links[edit]
-
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
